Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis

Abstract
The use of combination oral therapies in the management of severe psoriasis is gaining increasing acceptance. We report the concurrent use of mycophenolate mofetil (MMF) (maximum dose 3.0 g daily) wi...

This publication has 19 references indexed in Scilit: